The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Neurocrine Biosciences, Inc. shares valued at $2,643,020 were sold by BENEVICH ERIC on Apr 15 ’24. At $133.36 per share, BENEVICH ERIC sold 19,818 shares. The insider’s holdings dropped to 40,778 shares worth approximately $5.62 million following the completion of this transaction.
Also, Delaet Ingrid sold 272 shares, netting a total of over 37,346 in proceeds. Following the sale of shares at $137.30 each, the insider now holds 7,507 shares.
Before that, Delaet Ingrid had sold 5,000 shares from its account. In a trade valued at $725,320, the Chief Regulatory Officer traded Neurocrine Biosciences, Inc. shares for $145.06 each. Upon closing the transaction, the insider’s holdings decreased to 5,000 shares, worth approximately $1.03 million.
As published in a research note from Wells Fargo on April 24, 2024, Neurocrine Biosciences, Inc. [NBIX] has been rated up from an Equal weight to an Overweight and the price target has been revised to $170 from $140. As of December 12, 2023, Deutsche Bank has initiated its “Buy” rating for NBIX.
Analyzing NBIX Stock Performance
During the last five days, there has been a surge of approximately 3.94%. Over the course of the year, Neurocrine Biosciences, Inc. shares have jumped approximately 4.55%. Shares of the company reached a 52-week high of $148.37 on 03/21/24 and a 52-week low of $128.00 on 02/07/24. A 50-day SMA is recorded $136.47, while a 200-day SMA reached $121.19. Nevertheless, trading volume fell to 0.74 million shares from 1.61 million shares the previous day.
Support And Resistance Levels for Neurocrine Biosciences, Inc. (NBIX)
According to the 24-hour chart, there is a support level at 136.09, which, if violated, would cause prices to drop to 134.42. In the upper region, resistance lies at 139.40. The next price resistance is at 141.04. RSI (Relative Strength Index) is 52.71 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 3.22, which suggests the price will increase in the coming days. Percent R is at 48.69%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
